CD8A and neoplasm: In vivo, OC reverses CAF-mediated immunotherapy resistance: Combined with anti-PD-1, OC reduced TGF-β+ CAF infiltration by 60% in melanoma models, increasing CD8+ T cell cytotoxicity 2.3-fold and halting tumor progression [30].